ABEO stock news

ABEO stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

12 wire items

2026-10-23 18:46:00 UTC#508490newconfirmednews

James Russell discloses 6.1% stake in Abeona Therapeutics, seeks board and leadership changes

tradingviewimportance 0.50trust 0.80James Russell +0.30Abeona Therapeutics Inc. -0.30James Russell Revocable Trust 0

2026-09-18 09:55:00 UTC#332477duplicateconfirmednews

Cantor Fitzgerald raises Abeona Therapeutics price target to $30 from $28

dow_jonesimportance 0.30trust 0.70Abeona Therapeutics Inc. +0.30Cantor Fitzgerald, L.P. +0.30

2026-09-18 09:45:16 UTC#332413newconfirmednews

Cantor Fitzgerald maintains Overweight on Abeona Therapeutics, raises price target to $30

tradingviewimportance 0.40trust 0.70Cantor Fitzgerald, L.P. +0.30Abeona Therapeutics Inc. +0.50ZEVASKYN +0.40

2026-09-17 10:20:00 UTC#326475newconfirmednews

Roth Capital initiates Abeona Therapeutics (ABEO) at Buy with $17.00 price target

dow_jonesimportance 0.30trust 0.70Abeona Therapeutics, Inc. +0.40Roth Capital Partners, LLC +0.40

2026-09-16 17:20:35 UTC#322353duplicateconfirmednews

Abeona Therapeutics (ABEO) provides update on ZEVASKYN gene therapy launch and site expansion

quartrimportance 0.30trust 0.50Abeona Therapeutics, Inc. +0.40

2026-09-15 17:53:34 UTC#315951duplicateconfirmednews

Abeona Therapeutics (ABEO) highlights ZEVASKYN commercial launch and pipeline progress

quartrimportance 0.30trust 0.50Abeona Therapeutics Inc. +0.50ZEVASKYN +0.60

2026-09-15 17:38:32 UTC#315882newconfirmednews

Abeona Therapeutics reports strong ZEVASKYN launch momentum and pipeline expansion

quartrimportance 0.40trust 0.50Abeona Therapeutics Inc. +0.60ZEVASKYN +0.60

2026-08-13 19:57:10 UTC#174030newspeculationopinion

Seeking Alpha analysis suggests Abeona Therapeutics (ABEO) sell-off presents buying opportunity

seeking alphaimportance 0.30trust 0.40Abeona Therapeutics Inc. +0.20

2026-08-13 16:49:00 UTC#173292newconfirmednews

Abeona Therapeutics shifts to patient-treated revenue reporting, targets 85%-90% steady-state gross margins

seeking alphaimportance 0.40trust 0.70Abeona Therapeutics Inc. +0.20

2026-08-13 14:28:02 UTC#172451duplicateconfirmednews

Abeona Therapeutics reports Q2 2026 net revenue of $11.4M driven by ZEVASKYN expansion

quartrimportance 0.30trust 0.60Abeona Therapeutics Inc. +0.50ZEVASKYN +0.60

2026-08-13 11:35:25 UTC#171231newconfirmeddata release

Abeona Therapeutics Q2 GAAP EPS -$0.35 misses by $0.12, Revenue $11.38M misses by $0.78M

seeking alphaimportance 0.40trust 0.80Abeona Therapeutics, Inc. -0.50

2026-08-13 11:33:01 UTC#171268duplicateconfirmednews

Abeona Therapeutics Q2 2026: $11.4M ZEVASKYN revenue, $20.2M net loss

tradingviewimportance 0.30trust 0.80Abeona Therapeutics, Inc. -0.20ZEVASKYN +0.30